Oppenheimer cuts Wave Life Sciences target price to $29 from $32
WVE•Oppenheimer cut its target price for Wave Life Sciences to $29 from $32.
Related News
Reborn Coffee secures manufacturing infrastructure for $30 million supply volume through tri-party agreement
REBN•
India seeks $220 billion clean energy push to meet 2030 target
INDA•
US apartment vacancy rate falls to 7.8% in Q3, CoStar report shows
XLRE•
Genasys repays unsecured loan in full
GNSS•
Dropbox to cut workforce by about 9%
DBX•